share_log

6-K: Transaction Notification

SEC ·  Oct 10, 2024 11:04

Summary by Moomoo AI

On October 9, 2024, multiple senior executives of GSK acquired ordinary shares through the company's Share Reward Plan at £14.5185 per share on the London Stock Exchange. The transactions included both partnership and matching shares.CEO Emma Walmsley and CFO Julie Brown acquired 16 and 18 ordinary shares respectively. Other participating executives included James Ford (SVP and Group General Counsel), Sally Jackson (SVP, Global Communications), David Redfern (President, Corporate Development), Regis Simard (President, Global Supply Chain), Philip Thomson (President, Global Affairs), Deborah Waterhouse (CEO, ViiV Healthcare), and Victoria Whyte (Company Secretary), each acquiring between 16-18 shares.
On October 9, 2024, multiple senior executives of GSK acquired ordinary shares through the company's Share Reward Plan at £14.5185 per share on the London Stock Exchange. The transactions included both partnership and matching shares.CEO Emma Walmsley and CFO Julie Brown acquired 16 and 18 ordinary shares respectively. Other participating executives included James Ford (SVP and Group General Counsel), Sally Jackson (SVP, Global Communications), David Redfern (President, Corporate Development), Regis Simard (President, Global Supply Chain), Philip Thomson (President, Global Affairs), Deborah Waterhouse (CEO, ViiV Healthcare), and Victoria Whyte (Company Secretary), each acquiring between 16-18 shares.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more